Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Clenbuterol hydrochloride + nadolol) by CuraSen Therapeutics for Parkinson's Disease: Likelihood of Approval
(Clenbuterol hydrochloride + nadolol) is under clinical development by CuraSen Therapeutics and currently in Phase II for Parkinson's Disease. According...
(Clenbuterol hydrochloride + nadolol) by CuraSen Therapeutics for Mild Cognitive Impairment: Likelihood of Approval
(Clenbuterol hydrochloride + nadolol) is under clinical development by CuraSen Therapeutics and currently in Phase II for Mild Cognitive Impairment....
(Clenbuterol hydrochloride + nadolol) by CuraSen Therapeutics for Lewy Body Dementia: Likelihood of Approval
(Clenbuterol hydrochloride + nadolol) is under clinical development by CuraSen Therapeutics and currently in Phase II for Lewy Body Dementia....